17 FDA Advisers Back Maternal RSV Vaccine As Pfizer Says Safety Concerns Can Be Studied Post-Approvalš¤” (www.zerohedge.com) posted 1 year ago by dukey 1 year ago by dukey +17 / -0 FDA Advisers Back Maternal RSV Vaccine As Pfizer Says Safety Concerns Can Be Studied Post-Approval ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero 2 comments share 2 comments share save hide report block hide replies
The fact that ANY of the advisors-- let alone 4-- voted against recommending this vaccine-- SHOULD SCARE THE CRAP OUT OT EVERYONE.
Because these people will VOTE YES on literally every damn thing. They've never met a vax they don't like!
lol true. Who doesn't love money?